Profiteering Laws Fail Prostate Cancer Patients

Nov. 6 (Bloomberg) -- At up to $40,000 per patient, intensity-modulated radiation therapy, or IMRT, is one of the most profitable prostate cancer treatments for urologists, while not necessarily the most effective, according to several medical studies. One in five urologists now boost their income by billing for the therapy, according to a survey by the Urology Times. Bloomberg's Kevin Thrash reports on some urologists in Monterey County, California, who are being investigated by U.S. Department of Health and Human Services for possibly putting profits ahead of patients. (Source: Bloomberg)
Where Are Emerging Markets Headed?
45:12 - Viktor Shvets, head of Asian strategy at Macquarie Securities, discusses the outlook for emerging markets. He speaks to Bloomberg's Rishaad Salamat on "Trending Business." (Source: Bloomberg)
  • China's Entertainment Industry: a Blockbuster Investment?
  • China Slowdown Prompts Art Auctions to Go Online
  • The App Making Australian IPOs More Inclusive